Task: Type IB Variation

HL7 FHIR R5 – APIX Implementation Guide

Task Description

Validation of Type IB Variation

Core Task Information

Version ID 2 Task ID task-workflow-step2 Instance UUID urn:uuid:workflow-step1-instance Group Identifier urn:uuid:workflow-group-id-12345 Procedure ID EMEA/H/C/001234/IB/0025 Task Status accepted Business Status Validation Successful Intent order Priority routine

Code Type IB Variation (variation-type-ib) Authored 2025-11-15 09:00:00 UTC+01:00 Last Updated 2025-11-20 14:30:00 UTC+01:00

Parties Involved

Requester
SynthPharma AG
Address: 123 Synthetic Research Blvd, 4000 Basel, Switzerland
Contact: Dr. John Doe, Head of Regulatory Affairs
Email: john.doe@synthpharma.example
Performer
European Medicines Agency – Human Medicines Evaluation Division
Address: Domenico Scarlattilaan 6, 1083 HS Amsterdam, Netherlands
Contact: Scientific and Regulatory Management
Email: srm@ema.example.eu
Input Documents 10 documents

Module 1

Cover Letter
cover-letter
Cover Letter.pdf
Application Form
application-form
Application Form.pdf
Annotated Label
annotated-label
Annotated Label.pdf
Clean Label
clean-label
Clean Label.pdf
Pack Mockup
pack-mockup
Pack Mockup.pdf

Module 3

Stability Summary
cmc-stability-summary
CMC Doc 1 - Summary.pdf
Stability Data
cmc-stability-data
CMC Doc 2 - Data.pdf
Stability Commitment
cmc-stability-commitment
CMC Doc 3 - Commitment.pdf
DS Stability Summary
cmc-ds-stability-summary
CMC Doc 4 - DS Summary.pdf
DS Stability Data
cmc-ds-stability-data
CMC Doc 5 - DS Data.pdf
Output Documents 2 documents

Regulator Output

Acknowledgement of Receipt
acknowledgement-receipt
Acknowledgement_Letter.pdf
Validation Report
validation-report
Validation_Report.pdf